• The Central Drugs Standard Control Organisation (CDSCO) has asked commonly-used antibiotics manufacturers to ensure its details be made available to the general public.
• This decision was taken considering directives from the National Co-ordination Centre of the Pharmacovigilance Programme of India (PvPI).       

About PvPI 

• The PvPI was started by the Government of India on 14th July 2010 with the AIIMS New Delhi as the National Coordination Centre for monitoring Adverse Drug Reactions (ADRs) in the country for safe-guarding Public Health.
• Pharmacovigilance is defined as the science relating to the detection, assessment, understanding and prevention of adverse effects, principally long term and short term adverse effects of medicines. The CDSCO has a nation-wide Pharmacovigilance Programme for protecting the health of the patients by promising drug safety.

Objectives:

• To create a nation-wide system for patient safety reporting
• To identify and analyze the new signal (ADR) from the reported cases
• To analyses the benefit - risk ratio of marketed medications
• To generate the evidence based information on safety of medicines
• To support regulatory agencies in the decisionmaking process on use of medications
• To communicate the safety information on use of medicines to various stakeholders to minimize the risk
• To emerge as a national center of excellence for pharmacovigilance activities
• To collaborate with other national centers for the exchange of information and data management
• To provide training and consultancy support to other national pharmacovigilance centers located across

About CDSCO:

• The Central Drugs Standard Control Organisation(CDSCO) under Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India is the National Regulatory Authority (NRA) of India.
• Under the Drugs and Cosmetics Act, CDSCO is responsible for approval of New Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizations by providing expert advice with a view of bring about the uniformity in the enforcement of the Drugs and Cosmetics Act.
• CDSCO along with state regulators, is jointly responsible for grant of licenses of certain specialized categories of critical Drugs such as blood and blood products, I. V. Fluids, Vaccine and Sera.